Literature DB >> 3035236

Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer.

J P Donohue, R G Rowland, K Kopecky, C P Steidle, G Geier, K G Ney, L Einhorn, S Williams, P Loehrer.   

Abstract

A total of 80 patients with stage B3 or B2/C germ cell testis tumors underwent computerized tomography before and after chemotherapy. The volume and computerized tomographic density of metastatic retroperitoneal tumor were measured on all scans. The patients then underwent full bilateral retroperitoneal lymphadenectomy. The change in volume and density of retroperitoneal disease was correlated with the histological type of the primary testis tumor and with the histological findings at retroperitoneal lymphadenectomy. In all 15 patients (100 per cent) without teratomatous elements in the original tumor and who had a greater than 90 per cent decrease in the volume of retroperitoneal masses as a response to systemic chemotherapy no teratoma or active cancer was found in the surgical specimen. In contrast, 7 of 9 patients (78 per cent) with teratomatous elements in the original specimen had either teratoma or carcinoma in the retroperitoneal lymphadenectomy specimens despite having a greater than 90 per cent decrease in tumor volume. This difference was significant (p less than 0.05). These data suggest that patients with no teratomatous elements in the original specimen and a greater than 90 per cent decrease in the volume of retroperitoneal masses in response to chemotherapy can be observed carefully for signs of recurrence rather than undergoing post-chemotherapy retroperitoneal lymphadenectomy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035236     DOI: 10.1016/s0022-5347(17)44439-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

1.  Canadian consensus guidelines for the management of testicular germ cell cancer.

Authors:  Lori Wood; Christian Kollmannsberger; Michael Jewett; Peter Chung; Sebastian Hotte; Martin O'Malley; Joan Sweet; Lynn Anson-Cartwright; Eric Winquist; Scott North; Scott Tyldesley; Jeremy Sturgeon; Mary Gospodarowicz; Roanne Segal; Tina Cheng; Peter Venner; Malcolm Moore; Peter Albers; Robert Huddart; Craig Nichols; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

2.  Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.

Authors:  Samuel A Funt; Sujata Patil; Darren R Feldman; Robert J Motzer; Dean F Bajorin; Joel Sheinfeld; Satish K Tickoo; Victor E Reuter; George J Bosl
Journal:  J Clin Oncol       Date:  2019-06-24       Impact factor: 44.544

3.  Management of the post chemotherapy subcentimeter residual mass: the case for observation.

Authors:  Stephen D W Beck; Richard S Foster
Journal:  World J Urol       Date:  2009-07-15       Impact factor: 4.226

4.  Metastatic testicular germ cell tumour: the role of salvage surgery.

Authors:  K Suzuki; K Kurokawa; T Suzuki; S Jinbo; M Kobayashi; K Imai; H Yamanaka
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.

Authors:  J Baniel; B J Roth; R S Foster; J P Donohue
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

Review 6.  Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?

Authors:  Stephen B Riggs; Earl F Burgess; Kris E Gaston; Caroline A Merwarth; Derek Raghavan
Journal:  Oncologist       Date:  2014-04-09

7.  The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.

Authors:  Anna C Pfannenberg; Karin Oechsle; Carsten Bokemeyer; Christian Kollmannsberger; Bernhard M Dohmen; Roland Bares; Jörg T Hartmann; Reinhard Vonthein; Claus D Claussen
Journal:  World J Urol       Date:  2004-01-21       Impact factor: 4.226

8.  Size and status of metastases after inductive chemotherapy of germ-cell tumors. Indication for salvage operation.

Authors:  N Jaeger; L Weissbach; R Bussar-Maatz
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 9.  The role of positron emission tomography in germ cell cancer.

Authors:  Maria De Santis; Jörg Pont
Journal:  World J Urol       Date:  2004-03-16       Impact factor: 4.226

10.  Initial chemotherapy for stage II testicular non-seminoma.

Authors:  A Horwich; S Stenning
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.